학술논문

Identification of a novel combination treatment strategy in clear cell renal cell carcinoma stem cells with shikonin and ipilimumab.
Document Type
Article
Source
Frontiers in Immunology; 2023, p01-22, 22p
Subject
IPILIMUMAB
STEM cells
MONONUCLEAR leukocytes
SHIKONIN
IMMUNE checkpoint inhibitors
CANCER stem cells
RENAL cell carcinoma
Language
ISSN
16643224
Abstract
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)